The conflict between effective and affordable health care - A perspective from the developing world

Human Reproduction

Volumn 17, Issue 7, 2002, Pages 1680-1683

  Dyer, S J ^a  

^a Maternity Centre   (South Africa)

Author keywords

Assisted reproductive technology; Developing countries; Infertility care; RecombinantFSH; Urinary gonadotrophins

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

AFRICA; CLINICAL TRIAL; COMPARATIVE STUDY; DEVELOPING COUNTRY; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG MARKETING; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH ECONOMICS; HUMAN; INFERTILITY; INFERTILITY THERAPY; MEDICAL DECISION MAKING; META ANALYSIS; OVULATION INDUCTION; RESOURCE MANAGEMENT; REVIEW; UTERINE TUBE DISEASE;

EID: 0036065084     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.7.1680     Document Type: Review

References (25)

1. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: A meta-analysis
2. Pregnancy and birth in an in-vitro fertilization cycle after ovarian stimulation in a woman with a history of allergic reactions to human menopausal gonadotrophin
3. Making medicines affordable: The prize factor
4. Reproductive failure as a health priority in the third world: A review
5. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic chronic anovulation: A prospective, multicenter, assessor-blind, randomised, clinical trial
6. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction
7. Laparoscopic reconstructive tubal surgery in a tertiary referral centre - A review of 177 cases
8. The European IVF-monitoring programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 1998. Results generated from European registers by ESHRE
9. World Health Organization behavioural science research: Problems and prospects
10. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection
11. Social and cultural aspects of infertility in Mozambique
12. Laparoscopic fimbrioplasty and neosalpingostomy: Experience of the Yaounde General Hospital, Cameroon
13. Gonadotropic preparations - Lessons learned
14. Bye bye urinary gonadotropins
15. Oocyte maturation in vivo and in vitro
16. Pelvic inflammatory disease and its consequences in the developing world
17. HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: A prospective randomised trial
18. Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins
19. Ovarian stimulation during assisted reproductive treatment: A comparison of recombinant and highly purified urinary human FSH
20. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome
21. Infertility in the Gambia: Traditional and modern health care
22. Quality of infertility care in poor-resource areas and the introduction of new reproductive technologies
23. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: A prospective randomised study
24. Das Hormone der Hypophysenvoderlappens; Testobject zum Nachweis des Hormons